Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsBusinessBuy STC, Ceat, Dishman Pharma: Ashwani Gujral

    Buy STC, Ceat, Dishman Pharma: Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com suggests buying STC, Ceat and Dishman Pharma.

    April 13, 2017 / 15:43 IST

    Ashwani Gujral of ashwanigujral.com told CNBC-TV18, "STC is a buy with a stop loss of Rs 175, target of Rs 190 and Ceat with a stop loss of Rs 1430, target of Rs 1500."

    "Dishman Pharma is a buy with a stop loss of Rs 334, target of Rs 348," he added.

    first published: Apr 13, 2017 02:44 pm

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347